Suneel Gupta
Corporate Officer/Principal bei PROTAGONIST THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Suneel Gupta is currently the Chief Development Officer at Protagonist Therapeutics, Inc. He previously held positions as the VP-Clinical Pharmacology & Product Discovery at ALZA Corp from 1989 to 2001, Senior Vice President at Johnson & Johnson from 2002 to 2008, and Chief Scientific Officer at Impax Pharmaceuticals, Inc. from 2008 to 2019.
Dr. Gupta obtained his doctorate degree from The University of Manchester in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.02.2024 | 183 285 ( 0,31% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Suneel Gupta
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 17.01.2019 |
Ehemalige bekannte Positionen von Suneel Gupta
| Unternehmen | Position | Ende |
|---|---|---|
Impax Pharmaceuticals, Inc.
 Impax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Impax Pharmaceuticals, Inc. is an drug delivery company, which develops, manufactures and markets prescription pharmaceutical products. It is located in Hayward, CA. | Chief Tech/Sci/R&D Officer | 01.01.2019 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2008 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Suneel Gupta
| The University of Manchester | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Impax Pharmaceuticals, Inc.
Impax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Impax Pharmaceuticals, Inc. is an drug delivery company, which develops, manufactures and markets prescription pharmaceutical products. It is located in Hayward, CA. | Health Technology |
